Boeing (BA) stock has risen 32.3% over the past year, gaining 2.2% in the last month but slipping 3.5% in the past week. Despite this recent pullback, Wall Street’s analysts remain firmly optimistic, with a StrongBuy consensus and an average 12-month price target of $269.14 compared to the last closing price of $233.15. This implies meaningful upside potential over the coming year as investors look past short-term volatility and focus on Boeing’s longer-term recovery story.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Wall Street’s analysts are broadly bullish, forecasting further gains in Boeing as the company continues to work through operational challenges and ramps up production across key commercial programs. The consensus 12-month target of $269.14 suggests analysts expect the stock to climb from current levels as Boeing stabilizes its manufacturing and improves cash flow. For investors, the mix of solid recent performance over 12 months and a still-positive outlook may make Boeing a candidate for those seeking exposure to the aerospace recovery.
Among the most closely watched voices is Ronald Epstein of Bank of America, who reiterated his Buy rating on Boeing on February 3, 2026, and maintained a price target of $270.00, implying upside from the current price. Epstein describes Boeing as “an execution story that has wings,” arguing that the company’s path to recovery remains fundamentally sound even though the latest quarter highlighted that the journey is not without bumps. He notes that margins in both Commercial Airplanes and Defense have improved but still face headwinds from issues like the Spirit AeroSystems reintegration and another KC-46 charge.
Epstein sees “a lot to like” in Boeing’s commercial inflection, pointing to steady progress on core programs and stability in ramping production of the 737 and 787. He highlights promising certification progress on the 737-10 and 777-9, and he expects upside to Boeing’s 2026 delivery targets, projecting 504 737 MAX deliveries and 100 787 deliveries in that year. With a record commercial backlog of $567 billion, he argues that incremental production and certification milestones will be key catalysts for the stock, especially as new leadership under CEO Kelly Ortberg and CFO Jay Malave has removed some prior overhangs but left execution squarely in the spotlight.
Cash flow sits at the heart of Epstein’s thesis. He views 2026 as a transition year, with operational improvements driving progress toward Boeing’s long-term $10 billion free cash flow target. He forecasts free cash flow of about $3,019 million in 2026, slightly reduced from prior estimates but still on a trajectory that could allow Boeing to surpass its $10 billion objective by 2031. Epstein bases his valuation on normalized free cash flow of $11 per share and argues that stable production of the 737 and 787, along with inventory burn-down and fewer delays, can unlock significant value. This N-star analyst ranks #51 out of 11,984, with a 70.79% success rate and an impressive 22.90% average return per rating. Never miss a stock rating. Find all the latest ratings on TipRanks’ Top Wall Street Analysts page.

